SecBot SecBot
8-K ·Filed May 15, 2026

LFWD

Lifeward Ltd.
BEARISH
Impact 6/10
Horizonweeks Processed6mo ago SEC0001178913-26-002727
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

Revenue decline of 22% YoY and a 38% drop in the core AlterG segment signal ongoing operational headwinds, partially offset by improved cash burn and a stronger balance sheet. The delayed 10-Q and the massive S-3 overhang (261% of shares outstanding) create uncertainty. Watch for the 10-Q filing and any updates on AlterG order fulfillment in Q2/Q3. The stock is a high-risk micro-cap with a going-concern warning from the prior auditor.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Lifeward reported Q1 2026 revenue of $3.9M, down 22% YoY from $5.0M, and a GAAP net loss of $10.8M ($6.70/share) vs $4.8M ($5.53/share) a year ago. The headline miss is driven by a $4.9M non-cash acquired in-process R&D charge from the Oratech acquisition, but on an adjusted basis operating loss was flat at $4.6M. Cash burn improved 33% to $3.7M, and the balance sheet was strengthened to $11.4M cash after closing the Oramed strategic transaction and receiving $10M in financing. The 10-Q filing is delayed as the company finalizes accounting for the transaction.

Key Financial Metrics

EPS
−$6.70
est −$0.34 · -1870.6%
Revenue
$3.9M
est $5.8M · -32.4% · -22.1% YoY
Rating
miss
Gross Margin
34.2%

Key Facts

  • Q1 2026 revenue $3.9M, down 22% YoY from $5.0M
  • GAAP net loss $10.8M ($6.70/share) vs $4.8M ($5.53/share) YoY; includes $4.9M non-cash acquired in-process R&D charge
  • Non-GAAP adjusted operating loss flat at $4.6M YoY
  • Cash used in operations improved 33% to $3.7M from $5.5M YoY
  • Cash balance increased to $11.4M from $2.2M at Dec 2025, driven by $10M financing and $6.5M cash acquired from Oratech
  • ReWalk exoskeleton sales up 11% to $1.6M; AlterG revenue down 38% to $2.1M due to working capital constraints
  • 10-Q filing delayed as company finalizes accounting for the strategic transaction
  • S-3 filed 18 days ago registers 7.26M shares for resale (~261% of current shares outstanding) from selling shareholders

Financial Impact

Revenue miss of ~33% vs consensus ($3.9M actual vs $5.8M est); GAAP EPS miss of $6.70 vs $-0.34 consensus (driven by one-time charges)

revenueepsoperating cash flowcash balance

Risk Factors

  • Revenue declining 22% YoY with AlterG down 38% due to working capital constraints
  • 10-Q filing delay introduces uncertainty and potential compliance risk
  • Massive S-3 overhang of 261% of shares outstanding from selling shareholders
  • Going-concern warning from prior auditor (substantial doubt)
  • Gross margin compression from 42.2% to 34.2% YoY on lower production volumes and tariffs

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001178913-26-002727
Document: zk2635349.htm0001178913-26-002727
Document: 0001178913-26-002727-index-headers.html0001178913-26-002727
Document: 0001178913-26-002727-index.html0001178913-26-002727
Document: 0001178913-26-002727.txt0001178913-26-002727
8-K Data (Synthetic)0001178913-26-002727

Track record

25 reports on LFWD

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +20.27% at T+60 after the Aug 14, 2026 report. 9 of 9 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
  2. Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
  4. Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
  5. Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
  6. Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
  7. Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
  8. Aug 14, 202613w ago 8-K Mixed 6/10 No price data
  9. Aug 14, 202613w ago Press Release Bearish 6/10 Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
  10. Aug 11, 202614w ago EFFECT Bearish 7/10 Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 9h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026